Miri Halperin Wernli is a strategic healthcare executive with over 30 years of leadership in the life sciences, biotech, and pharmaceutical industries at companies like Roche, Merck, and Actelion. A scientist and entrepreneur with a Doctorate from the University of Geneva and an Executive MBA from Stanford, she has deep expertise in drug development and corporate strategy.
She has a keen intellectual curiosity in the convergence of technology, nature, and human experience. Her interests range from the complexities of animal behavior and the natural world to the philosophical implications of artificial intelligence and the intersection of nutrition with biotechnology for healthy aging.
Her board directorships showcase a unique blend of interests, spanning from precision neuropsychiatry and humanitarian aid technology to wellness retreats that incorporate plant-assisted experiences.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.